BioAtla, Inc. - Common Stock (NQ:BCAB)

0.8144 -0.0094 (-1.14%)

Streaming Delayed Price Updated: 2:28 PM EST, Dec 8, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioAtla, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Curious about the stocks that are showing activity after the closing bell on Friday? ↗

November 28, 2025

As the regular session of the US market concludes on Friday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

Get insights into the top gainers and losers of Friday's after-hours session. ↗

November 21, 2025

Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 18, 2025

Via Benzinga

Earnings Scheduled For November 13, 2025 ↗

November 13, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

A Preview Of BioAtla's Earnings ↗

May 05, 2025

Via Benzinga

Earnings Outlook For BioAtla ↗

March 26, 2025

Via Benzinga

Which stocks are moving on Friday? ↗

November 14, 2025

Intrigued by the market activity in the middle of the day on Friday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

BioAtla Inc (NASDAQ:BCAB) Reports Narrower-Than-Expected Q3 2025 Loss ↗

November 13, 2025

BioAtla (BCAB) beat Q3 2025 EPS estimates, sending its stock up 7.5%. The biotech also gained FDA alignment for its Phase 3 trial in head and neck cancer.

Via Chartmill

BioAtla (BCAB) Q3 2025 Earnings Call Transcript ↗

November 13, 2025

BioAtla (BCAB) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

What's Next: BioAtla's Earnings Preview ↗

November 12, 2025

Via Benzinga

BCAB Stock Earnings: BioAtla Meets EPS for Q2 2024 ↗

August 08, 2024

BCAB stock results show that BioAtla met analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

BCAB Stock Earnings: BioAtla Beats EPS for Q1 2024 ↗

May 14, 2024

BCAB stock results show that BioAtla beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 20, 2025

Via Benzinga

These stocks are moving in today's session ↗

October 20, 2025

Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 16, 2025

Via Benzinga

BioAtla (BCAB) Q2 Loss Narrows 27% ↗

August 07, 2025

Via The Motley Fool

Topics Intellectual Property

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 09, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 21, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 14, 2025

Via Benzinga

Earnings Scheduled For March 27, 2025 ↗

March 27, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 17, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 20, 2024

Via Benzinga

'Big Short' Investor Michael Burry's China Bet Pays Off As Top Picks Surge Nearly 60% In 2 Months ↗

October 09, 2024

Michael Burry, the investor renowned for his prescient bet against the housing market before the 2008 financial crisis, has seen his recent wager on Chinese stocks pay significant dividends.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 02, 2024

Via Benzinga

BioAtla and Context Therapeutics Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362, a Nectin-4 x CD3 T Cell Engaging Antibody

September 23, 2024

From Context Therapeutics Inc.

Via GlobeNewswire

'Big Short' Fame Michael Burry Bets Big On China, Reveals Alibaba As Top Holding — JD.com And Baidu Also Feature On Scion's Portfolio ↗

August 15, 2024

Famed investor Michael Burry, known for his prescient bet against the housing market before the 2008 financial crisis, has made significant changes to his hedge fund's portfolio in the second quarter...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 14, 2024

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.